Shanghai Fosun Pharmaceutical Group Co Ltd (600196) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.038x

Based on the latest financial reports, Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a cash flow conversion efficiency ratio of 0.038x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.40 Billion ≈ $350.75 Million USD) by net assets (CN¥62.49 Billion ≈ $9.14 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanghai Fosun Pharmaceutical Group Co L defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Shanghai Fosun Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Fosun Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Fosun Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fosun Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Do-Fluoride Chemicals Co Ltd SHE:002407	0.026x
Beijer Ref AB (publ) ST:BEIJ-B	0.028x
HELLENIC TELEC.ORG.ADR1/2 F:OTES	0.168x
Giant Network Group Co Ltd SHE:002558	0.077x
GPT Group AU:GPT	0.035x
NINGBO SHANSHAN GDR/A F:OJ8	N/A
NIBE Industrier AB (publ) ST:NIBE-B	0.100x
Madison Air Solutions Corporation NYSE:MAIR	0.056x

Annual Cash Flow Conversion Efficiency for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600196 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥62.49 Billion ≈ $9.14 Billion	CN¥6.01 Billion ≈ $878.76 Million	0.096x	+28.64%
2024-12-31	CN¥59.93 Billion ≈ $8.77 Billion	CN¥4.48 Billion ≈ $655.12 Million	0.075x	-3.07%
2023-12-31	CN¥56.62 Billion ≈ $8.28 Billion	CN¥4.36 Billion ≈ $638.48 Million	0.077x	-1.13%
2022-12-31	CN¥54.11 Billion ≈ $7.92 Billion	CN¥4.22 Billion ≈ $617.16 Million	0.078x	-4.51%
2021-12-31	CN¥48.38 Billion ≈ $7.08 Billion	CN¥3.95 Billion ≈ $577.83 Million	0.082x	+45.50%
2020-12-31	CN¥45.98 Billion ≈ $6.73 Billion	CN¥2.58 Billion ≈ $377.50 Million	0.056x	-31.75%
2019-12-31	CN¥39.20 Billion ≈ $5.74 Billion	CN¥3.22 Billion ≈ $471.54 Million	0.082x	-6.40%
2018-12-31	CN¥33.59 Billion ≈ $4.92 Billion	CN¥2.95 Billion ≈ $431.69 Million	0.088x	+1.23%
2017-12-31	CN¥29.74 Billion ≈ $4.35 Billion	CN¥2.58 Billion ≈ $377.57 Million	0.087x	+3.82%
2016-12-31	CN¥25.25 Billion ≈ $3.69 Billion	CN¥2.11 Billion ≈ $308.77 Million	0.084x	+6.55%
2015-12-31	CN¥20.67 Billion ≈ $3.02 Billion	CN¥1.62 Billion ≈ $237.21 Million	0.078x	+24.82%
2014-12-31	CN¥19.10 Billion ≈ $2.80 Billion	CN¥1.20 Billion ≈ $175.63 Million	0.063x	+9.71%
2013-12-31	CN¥17.66 Billion ≈ $2.58 Billion	CN¥1.01 Billion ≈ $148.03 Million	0.057x	+31.70%
2012-12-31	CN¥15.30 Billion ≈ $2.24 Billion	CN¥665.52 Million ≈ $97.39 Million	0.043x	+56.15%
2011-12-31	CN¥11.37 Billion ≈ $1.66 Billion	CN¥316.65 Million ≈ $46.34 Million	0.028x	+28.63%
2010-12-31	CN¥9.39 Billion ≈ $1.37 Billion	CN¥203.36 Million ≈ $29.76 Million	0.022x	-42.52%
2009-12-31	CN¥6.95 Billion ≈ $1.02 Billion	CN¥261.87 Million ≈ $38.32 Million	0.038x	-28.14%
2008-12-31	CN¥4.45 Billion ≈ $650.58 Million	CN¥233.04 Million ≈ $34.10 Million	0.052x	+72.08%
2007-12-31	CN¥4.32 Billion ≈ $631.62 Million	CN¥131.48 Million ≈ $19.24 Million	0.030x	-39.90%
2006-12-31	CN¥3.65 Billion ≈ $533.90 Million	CN¥184.91 Million ≈ $27.06 Million	0.051x	-22.64%
2005-12-31	CN¥2.88 Billion ≈ $420.71 Million	CN¥188.35 Million ≈ $27.56 Million	0.066x	-10.12%
2004-12-31	CN¥2.81 Billion ≈ $411.75 Million	CN¥205.10 Million ≈ $30.01 Million	0.073x	-2.08%
2003-12-31	CN¥2.02 Billion ≈ $295.14 Million	CN¥150.14 Million ≈ $21.97 Million	0.074x	+21.56%
2002-12-31	CN¥1.67 Billion ≈ $244.87 Million	CN¥102.47 Million ≈ $15.00 Million	0.061x	+18.84%
2001-12-31	CN¥1.32 Billion ≈ $193.54 Million	CN¥68.15 Million ≈ $9.97 Million	0.052x	-54.64%
2000-12-31	CN¥1.22 Billion ≈ $178.30 Million	CN¥138.43 Million ≈ $20.26 Million	0.114x	+95.42%
1999-12-31	CN¥657.08 Million ≈ $96.15 Million	CN¥38.20 Million ≈ $5.59 Million	0.058x	-53.64%
1998-12-31	CN¥530.77 Million ≈ $77.67 Million	CN¥66.55 Million ≈ $9.74 Million	0.125x	--

About Shanghai Fosun Pharmaceutical Group Co Ltd

SHG:600196 China Drug Manufacturers - Specialty & Generic

Market Cap

$6.75 Billion

CN¥46.16 Billion CNY

Market Cap Rank

#2972 Global

#394 in China

Share Price

CN¥21.79

Change (1 day)

+0.97%

52-Week Range

CN¥21.58 - CN¥32.15

All Time High

CN¥85.06